Home
»
Press Room
»
MicroRNA Market To Reach $5.48Bn By 2033 | CAGR 13.64%

MicroRNA Market To Reach $5.48 Billion By 2033 | CAGR 13.64%

November 2025 | Report Format: Electronic (PDF)

MicroRNA Market Growth & Trends

The global microRNA market size is expected to reach USD 5.48 billion by 2033, registering a CAGR of 13.64% from 2025 to 2033, according to a new report by Grand View Research, Inc. The growth of the market is propelled by substantial investments in research and development initiatives for the development of novel diagnostic tests and therapeutics, coupled with the successful integration of microRNAs in clinical trials. The biopharmaceutical sector plays a significant role in the current biotechnology industry. The expenditure on R&D has significantly increased in the biotechnology industry. Several biopharmaceutical companies are investing in the development of RNA-based therapeutics (miRNAs & siRNAs). Some of the major players are Regulus Therapeutics, Rosetta Genomics, Alnylam Pharmaceuticals, miRagen Therapeutics, and Mirna Therapeutics.

The substantial investments coupled with increased government funding in miRNA R&D initiatives for the development of new diagnostic tests & therapeutics are anticipated to boost the market growth. Several new players have arrived in the market with innovative approaches for the development of targeted therapeutics and identifying drug targets. For instance, in an article published in Elsevier in April 2022, a team of researchers provided a summary of current large-cohort studies that show the clinical value of circulating miRNAs for the early diagnosis of disease.

The rising number of studies investigating the tumor-suppressive effects of various microRNAs, particularly in cancer cell lines like thoracic cancer, is driving an increased demand for microRNA research tools. Additionally, miRNA-based therapeutics have demonstrated high potential in the treatment of various diseases and are continuously evolving. Accurate delivery of miRNA-based therapeutic agents to the targeted cells remains a major challenge for clinical applications. However, the recent introduction of efficient delivery systems, such as nanoparticle-based delivery systems, is anticipated to help overcome this challenge.

key Request a free sample copy or view report summary: MicroRNA Market Report

MicroRNA Market Report Highlights

By product & services, the service segment held the largest revenue share in 2024. The product segment is anticipated to witness significant market growth over the forecast period.
By application, the cancer segment accounted for the largest revenue share in 2024 of 36.65%. The infectious disease segment is estimated to register the fastest CAGR over the forecast period.
By end-use, the biotechnology and pharmaceutical companies segment dominated the market in 2024 of 46.09%. The academic and government research institutes segment is expected to witness strong growth, driven by the extensive use of miRNA techniques across a rising number of research studies.
North America dominated the microRNA industry in 2024 with the largest share of 42.06%. The U.S. held a significant share of the North American market in 2024
The Asia Pacific region is expected to grow at the fastest CAGR of 13.64% during the forecast period.

MicroRNA Market Segmentation

Grand View Research has segmented global microRNA market on the basis of product & service, application, end-use, and region:

MicroRNA Product & Services Outlook (Revenue in USD Million, 2021 - 2033)

Services
- Type
  - Isolation & Purification
  - miRNA cDNA Synthesis
  - Profiling, Localization, & Quantification
  - Functional Analysis
  - Others
- Specimen
  - Whole Blood
  - Serum
  - Plasma
  - FFPE
  - Fresh Frozen Tissue
  - Others
Products
- Instruments
  - Technology
    - Real Time PCR
    - Microarray
    - NGS
    - Others
  - Workflow
    - Isolation & Purification
    - miRNA cDNA Synthesis
    - Profiling, Localization, & Quantification
    - Functional Analysis & Others
    - Others
- Consumables
  - Specimens
    - Whole Blood
    - Serum
    - Plasma
    - FFPE
    - Fresh Frozen Tissue
    - Others
  - Workflow
    - Isolation & Purification
    - miRNA cDNA Synthesis
    - Profiling, Localization, & Quantification
    - Functional Analysis
    - Others